MedTech Company Selling Novel, 510(k)-Exempt Nasal Airway Device IP/Assets

This is an opportunity to acquire a U.S.-based medical technology company focused on airway management, featuring a novel, single-use nasal airway device. The technology is designed to secure the airway supraglotically, avoiding the vocal cords and eliminating the need for paralytic drugs, offering significant advantages over existing LMA and tracheostomy tubes. The device is Class I and 510(k)-exempt, facilitating rapid market entry. The company possesses a strong intellectual property position covering device geometry and multi-lumen functionality. With prototypes validated and supply chain established for scale, the business projects high gross margins exceeding 70% via outsourced manufacturing. This asset is positioned as a strategic bolt-on acquisition for global airway or trauma device platforms. Flexible transaction structures are available.